S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
Log in

NASDAQ:ATRI - Atrion Stock Price, Forecast & News

$702.91
+11.89 (+1.72 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$698.00
Now: $702.91
$709.79
50-Day Range
$684.80
MA: $750.55
$848.00
52-Week Range
$671.05
Now: $702.91
$948.03
Volume253 shs
Average Volume6,422 shs
Market Capitalization$1.30 billion
P/E Ratio35.26
Dividend Yield0.90%
Beta0.14
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$152.45 million
Cash Flow$23.85 per share
Book Value$113.76 per share

Profitability

Net Income$34.26 million

Miscellaneous

Employees570
Market Cap$1.30 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.


Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Tuesday, November 12th. Investors of record on Monday, December 2nd will be paid a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date is Friday, November 29th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) posted its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 EPS for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a return on equity of 16.45% and a net margin of 23.43%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion.

Has Atrion been receiving favorable news coverage?

Media coverage about ATRI stock has been trending somewhat positive recently, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Atrion earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Atrion.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include ABM Industries (ABM), Alaska Air Group (ALK), Chemed (CHE), Walt Disney (DIS), Boston Beer (SAM), Analog Devices (ADI), Amgen (AMGN), Comcast (CMCSA), CSX (CSX) and J & J Snack Foods (JJSF).

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (2.46%), Boston Trust Walden Corp (0.72%), Pennsylvania Trust Co (0.56%), Rhumbline Advisers (0.37%), First Trust Advisors LP (0.29%) and California Public Employees Retirement System (0.22%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.

Which major investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, First Trust Advisors LP, Virginia Retirement Systems ET AL, Barclays PLC, First Quadrant L P CA and Eagle Ridge Investment Management. Company insiders that have sold Atrion company stock in the last year include John P Stupp Jr and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.

Which major investors are buying Atrion stock?

ATRI stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, SG Americas Securities LLC, Rhumbline Advisers, Nisa Investment Advisors LLC, Squarepoint Ops LLC, California Public Employees Retirement System, OLD Dominion Capital Management Inc. and Boston Trust Walden Corp. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $702.91.

How big of a company is Atrion?

Atrion has a market capitalization of $1.30 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion.

What is Atrion's official website?

The official website for Atrion is http://www.atrioncorp.com/.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  105 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  225
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel